Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia

September 13, 2021
9:00 am

Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia

Providence grants Everest license to develop and market potentially “Best-In-Class” mRNA COVID-19 vaccine for select Asia territories
Providence and Everest enter into a 50/50 worldwide collaboration to jointly develop products in two additional indications,…

Click here to view the original article.